EUCTR2011-005822-23-NO进行中（未招募）不适用
CONTINUOUS SUBCUTANEOUS HYDROCORTISONE INFUSION IN CONGENITAL ADRENAL HYPERPLASIA
Haukeland University Hospital0 个研究点开始时间: 2013年2月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Verified salt-wasting CAH
- •Written informed consent. If the patient is between 15-16 years old both the patient and the parents will have to give informed consent.
- •In case of concomitant endocrine/autoimmune diseases these should be on stable treatment during the study period.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 5
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with diabetes mellitus on insulin pump treatment will not be included in this study. Other exclusion criteria are cardiovascular disease, malignant disease and pregnancy, and pharmacological treatment with glucocorticoids or drugs that interfere with cortisol metabolism (antiepileptics, rifampicin, St. Johns wart). The patients should not take grapefruit juice the last two weeks before or during the study period.
研究者
相似试验
进行中（未招募）
1 期
A trial comparing continuous subcutaneous hydrocortisone infusion (CSHI) therapy with conventional oral glucocorticoid therapy in patients with Congenital Andrenal Hyperplasia (CAH)Congenital Adrenal HyperplasiaMedDRA version: 14.1Level: LLTClassification code 10010323Term: Congenital adrenal hyperplasiaSystem Organ Class: 100000004850EUCTR2011-005822-23-SEHaukeland University Hospital20
进行中（未招募）
不适用
A trial comparing continuous subcutaneous hydrocortisone therapy with pulsatile subcutaneous hydrocortisone therapy in patients with Addison`s diseaseEUCTR2013-004189-33-NOHaukeland University Hospital10
已完成
不适用
How are repeat(ed) steroid injections into osteoarthritic joints used and what are the outcomes?OsteoarthritisISRCTN32433800niversity of Bristol148
招募中
不适用
Prevention of antivenom reactions by administering intravenous hydrocortosne 2 hours before antivenom treatmentSnake bite,antivenom reactionsSLCTR/2010/005Prof SAM Kularatne
已完成
不适用
Continuous subcutaneous injection of octreotide for congtenital hyperinsulinism: efficacy and safety.congenital hyperinsulinismJPRN-UMIN000012620Japan Agency for Medical Research and Development. Research group for the study on "Efficacy and safety of subcutaneous continuous octreotide infusion for congenital hyperinsulinism."7